Many pharmaceutical companies such as Chutian Technology intend to be selected as the "2021 Smart Manufacturing Pilot Demonstration Factory Unveiling Unit"

 According to the "Notice on Carrying Out 2021 Smart Manufacturing Pilot Demonstration Actions" (Industry and Information Technology Department Unicom Zhuanghan [2021] No.
263), the Ministry of Industry and Information Technology recently announced the list of units and outstanding scenarios of the proposed smart manufacturing pilot demonstration factories in 2021.
Publicity
.
The announcement time is from December 28, 2021 to January 4, 2022
.
According to the author, Jiangsu Yuyue Medical Equipment Co.
, Ltd.
, Chutian Technology Co.
, Ltd.
, Hunan Kelun Pharmaceutical Co.
, Ltd.
, Mecang Biotechnology Co.
, Ltd.
, China Resources Sanjiu Pharmaceutical Co.
, Ltd.
and many other pharmaceutical companies are planned to be selected "In 2021 the Smart Manufacturing Pilot Demonstration Factory Unveiling Unit"
.
Jiangsu Yuyue Medical Equipment Co.
, Ltd.
unveiled the task name: the typical scene name of the high-end medical diagnosis and treatment equipment intelligent manufacturing demonstration factory includes direct user manufacturing; procurement strategy optimization, intelligent warehousing, real-time logistics monitoring and optimization, discrete process digital design, and production planning Optimization, advanced process control, intelligent online detection, online operation monitoring and fault diagnosis
.
It is understood that Yuyue Medical actively embraces the changes of the times and has shown great tolerance for cutting-edge technologies such as big data and artificial intelligence technology
.
Its global production base has been continuously developing towards the "smart fish leap" system, and is expected to become a digital service center integrating smart products, smart factories, and big data service platforms in the next period of time
.
Relevant persons in Yuyue Medical said that in the future, digital reform will open up a new model of open supply chain.
Only by opening the supply chain to users can it better improve efficiency and improve the quality of industrial development
.
Yuyue Medical has promoted demand-side reforms through innovative measures such as supply chain opening up, allowing R&D to start from users and return to users
.
Chutian Technology Co.
, Ltd.
unveiled the task name: the typical scene name of the medical equipment intelligent manufacturing demonstration factory includes process-based digital design, production planning optimization, flexible production line configuration, lean production management, intelligent warehousing, product quality optimization, online operation monitoring and Fault diagnosis and optimization of purchasing strategy
.
Chutian Technology has now developed into one of the major companies in the world's medical equipment industry
.
The main business is medical equipment and its overall technical solutions, and early promotion of the research and development of smart pharmaceutical factories
.
Chutian Technology actively implements strategic goals, continuously improves market and marketing capabilities, strengthens internal operation and management capabilities, and gives full play to the synergy effects of various subsidiaries
.
In 2019, the company's pharmaceutical equipment sales have risen sharply, and in 2020, the sales of pharmaceutical equipment will also achieve 3113 lines/set
.
The company's pharmaceutical equipment has been in short supply for two consecutive years.
In the middle and late stages, the company continued to improve its quality and technical performance
.
Hunan Kelun Pharmaceutical Co.
, Ltd.
unveiled the task name: the typical scene name of the pharmaceutical intelligent manufacturing demonstration factory includes advanced process control, intelligent online inspection, production plan optimization, asset life cycle management, intelligent warehousing, supply chain visualization, real-time logistics monitoring and optimization, Dynamic optimization of sales plan
.
Kelun Pharmaceuticals, which is rooted in innovative research and development, has continued to innovate in recent years.
From the field of infusion to the "three-engine drive", it is ushering in a critical moment for new products to be launched one after another
.
After 10 years of deployment, Kelun Pharmaceutical has invested more than 7 billion yuan in R&D and innovation
.
Wind data shows that from 2015 to 2019, the company's R&D investment was 498 million yuan, 613 million yuan, 846 million yuan, 1.
114 billion yuan, and 1.
351 billion yuan
.
In 2020, the company's annual R&D investment increased by 12.
24% year-on-year to 1.
516 billion yuan
.
Meikang Biotechnology Co.
, Ltd.
unveiled the task name: in vitro diagnostic reagents and supporting equipment intelligent manufacturing demonstration factory.
Typical scene names include lean production management, human-machine collaboration, production plan optimization, intelligent warehousing, accurate quality traceability, and asset life cycle management , Sales-driven business optimization, and procurement strategy optimization
.
Mekang Bio is a national high-tech enterprise specializing in the research and development, production, sales and service of in vitro diagnostic products
.
At present, Mecang Bio’s product line covers the fields of biochemistry, chemiluminescence immunoassay, mass spectrometry, VAP blood lipid sub-component detection, blood cells, urine and POCT, with a wide range of products
.
At the same time, the company has the systematic professional ability to develop and produce in vitro diagnostic instruments, reagents, calibration products and quality control products, and has completed the upstream and downstream industrial chain layout from biological raw materials, in vitro diagnostic products to professional services
.
China Resources Sanjiu Pharmaceutical Co.
, Ltd.
unveiled the task name: the typical scene names of the pharmaceutical intelligent manufacturing demonstration factory include human-machine collaborative operation, intelligent warehousing, intelligent online inspection, multi-factory production planning coordination, accurate quality traceability, predictive maintenance and operation optimization, and the market Rapid analysis and forecasting, real-time monitoring and optimization of logistics
.
China Resources Sanjiu is mainly engaged in the research and development, production, sales and related health services of pharmaceutical products.
The main products include 999 Ganmaoling, 999 Piyanping, Shenfu injection, cephalosporin for injection, Chinese medicine for free decoction, Sanjiu Weitai granules, Zhengtian Pills and so on
.
In the process of development, China Resources Sanjiu follows the development characteristics of traditional Chinese medicine and formulated a long-term research and development plan for traditional Chinese medicine around "innovative traditional Chinese medicine + development of classic prescriptions + development of in-hospital preparations"
.
Among them, in terms of innovative Chinese medicine, focus on the varieties of Chinese medicine with unique curative effect, clarify the clinical scientific value of products, and cultivate large varieties of Chinese medicine; in the development of classic prescriptions, continue to increase the selection and establishment of projects, and carry out related research such as material benchmarks.
There are more than ten classic names, and some of the varieties under research have completed the application materials; in the hospital preparations, the system is actively screened and collected to make reserves for the introduction of new products
.